The Filings Report

Bunge Global SA

BGNYSECIK 1996862Consumer Defensive / Packaged Foods & Farm Productsfiscal year ends December20 quarters since 2021

Revenue, Q3 FY2026
$23.8B
+7.4% on Q3 FY2025
Net income
$318M
+91.6% on Q3 FY2025
Free cash flow
−$1.6B
−505.2% on Q3 FY2025
Diluted EPS
$1.64
+95.2% on Q3 FY2025
Revenue, TTM
$93.5B
trailing four quarters
Net margin, TTM
1.2%
net income $1.2B
Free cash flow, TTM
−$2.7B
−$955M less $1.7B capex
Cash and equivalents
$524M
long-term debt $8.9B, Sep 30, 2026
Shares, 12-month change
−0.6%
192M shares, Sep 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$549M
3.0% of market value
Market value
$18.6B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Bunge Global SA reported revenue of $23.8B, +7.4% on Q3 FY2025, and net income of $318M (+91.6%). Free cash flow, operating cash flow less capital expenditures, was −$1.6B (−$1.2B less $384M). Diluted earnings per share were $1.64.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.

Revenue and net incomeRevenueNet income
$0$10B$20B$30BQ4'22, Revenue: $16.7BQ4'22, Net income: $336MQ4'22Q1'23, Revenue: $15.3BQ1'23, Net income: $632MQ1'23Q2'23, Revenue: $15.0BQ2'23, Net income: $622MQ2'23Q3'23, Revenue: $14.2BQ3'23, Net income: $373MQ3'23Q4'23, Revenue: $14.9BQ4'23, Net income: $616MQ4'23Q1'24, Revenue: $13.4BQ1'24, Net income: $244MQ1'24Q2'24, Revenue: $13.2BQ2'24, Net income: $70MQ2'24Q3'24, Revenue: $12.9BQ3'24, Net income: $221MQ3'24Q4'24, Revenue: $13.5BQ4'24, Net income: $602MQ4'24Q1'25, Revenue: $11.6BQ1'25, Net income: $201MQ1'25Q2'25, Revenue: $12.8BQ2'25, Net income: $354MQ2'25Q3'25, Revenue: $22.2BQ3'25, Net income: $166MQ3'25Q4'25, Revenue: $23.8BQ4'25, Net income: $95MQ4'25Q1'26, Revenue: $21.9BQ1'26, Net income: $68MQ1'26Q2'26, Revenue: $24.0BQ2'26, Net income: $678MQ2'26Q3'26, Revenue: $23.8BQ3'26, Net income: $318MQ3'26$0$10B$20B$30BQ4'22, Revenue: $16.7BQ4'22, Net income: $336MQ1'23, Revenue: $15.3BQ1'23, Net income: $632MQ1'23Q2'23, Revenue: $15.0BQ2'23, Net income: $622MQ3'23, Revenue: $14.2BQ3'23, Net income: $373MQ3'23Q4'23, Revenue: $14.9BQ4'23, Net income: $616MQ1'24, Revenue: $13.4BQ1'24, Net income: $244MQ1'24Q2'24, Revenue: $13.2BQ2'24, Net income: $70MQ3'24, Revenue: $12.9BQ3'24, Net income: $221MQ3'24Q4'24, Revenue: $13.5BQ4'24, Net income: $602MQ1'25, Revenue: $11.6BQ1'25, Net income: $201MQ1'25Q2'25, Revenue: $12.8BQ2'25, Net income: $354MQ3'25, Revenue: $22.2BQ3'25, Net income: $166MQ3'25Q4'25, Revenue: $23.8BQ4'25, Net income: $95MQ1'26, Revenue: $21.9BQ1'26, Net income: $68MQ1'26Q2'26, Revenue: $24.0BQ2'26, Net income: $678MQ3'26, Revenue: $23.8BQ3'26, Net income: $318MQ3'26

Net income losses drawn in red.

Free cash flow
−$2B−$1B$0$1B$2BQ4'22Q1'23, Free cash flow: $758MQ1'23Q2'23, Free cash flow: −$827MQ2'23Q3'23, Free cash flow: $1.1BQ3'23Q4'23, Free cash flow: $1.1BQ4'23Q1'24, Free cash flow: $758MQ1'24Q2'24, Free cash flow: −$1.8BQ2'24Q3'24, Free cash flow: $973MQ3'24Q4'24, Free cash flow: $564MQ4'24Q1'25, Free cash flow: −$595MQ1'25Q2'25, Free cash flow: −$1.5BQ2'25Q3'25, Free cash flow: $385MQ3'25Q4'25, Free cash flow: $809MQ4'25Q1'26, Free cash flow: −$877MQ1'26Q2'26, Free cash flow: −$1.0BQ2'26Q3'26, Free cash flow: −$1.6BQ3'26−$2B−$1B$0$1B$2BQ1'23, Free cash flow: $758MQ1'23Q2'23, Free cash flow: −$827MQ3'23, Free cash flow: $1.1BQ3'23Q4'23, Free cash flow: $1.1BQ1'24, Free cash flow: $758MQ1'24Q2'24, Free cash flow: −$1.8BQ3'24, Free cash flow: $973MQ3'24Q4'24, Free cash flow: $564MQ1'25, Free cash flow: −$595MQ1'25Q2'25, Free cash flow: −$1.5BQ3'25, Free cash flow: $385MQ3'25Q4'25, Free cash flow: $809MQ1'26, Free cash flow: −$877MQ1'26Q2'26, Free cash flow: −$1.0BQ3'26, Free cash flow: −$1.6BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$3B$5B$8B$10BQ4'22, Cash and equivalents: $1.1BQ4'22, Long-term debt: $3.3BQ4'22Q1'23, Cash and equivalents: $3.1BQ1'23Q2'23, Cash and equivalents: $1.3BQ2'23Q3'23, Cash and equivalents: $2.2BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23, Long-term debt: $4.1BQ4'23Q1'24, Cash and equivalents: $2.9BQ1'24, Long-term debt: $4.1BQ1'24Q2'24, Cash and equivalents: $1.2BQ2'24, Long-term debt: $4.1BQ2'24Q3'24, Cash and equivalents: $2.8BQ3'24, Long-term debt: $4.8BQ3'24Q4'24, Cash and equivalents: $3.3BQ4'24, Long-term debt: $4.7BQ4'24Q1'25, Cash and equivalents: $3.2BQ1'25, Long-term debt: $4.7BQ1'25Q2'25, Cash and equivalents: $6.8BQ2'25, Long-term debt: $7.0BQ2'25Q3'25, Cash and equivalents: $1.3BQ3'25, Long-term debt: $9.8BQ3'25Q4'25, Cash and equivalents: $1.1BQ4'25, Long-term debt: $8.8BQ4'25Q1'26, Cash and equivalents: $839MQ1'26, Long-term debt: $9.9BQ1'26Q2'26, Cash and equivalents: $593MQ2'26, Long-term debt: $9.4BQ2'26Q3'26, Cash and equivalents: $524MQ3'26, Long-term debt: $8.9BQ3'26$0$3B$5B$8B$10BQ4'22, Cash and equivalents: $1.1BQ4'22, Long-term debt: $3.3BQ1'23, Cash and equivalents: $3.1BQ1'23Q2'23, Cash and equivalents: $1.3BQ3'23, Cash and equivalents: $2.2BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23, Long-term debt: $4.1BQ1'24, Cash and equivalents: $2.9BQ1'24, Long-term debt: $4.1BQ1'24Q2'24, Cash and equivalents: $1.2BQ2'24, Long-term debt: $4.1BQ3'24, Cash and equivalents: $2.8BQ3'24, Long-term debt: $4.8BQ3'24Q4'24, Cash and equivalents: $3.3BQ4'24, Long-term debt: $4.7BQ1'25, Cash and equivalents: $3.2BQ1'25, Long-term debt: $4.7BQ1'25Q2'25, Cash and equivalents: $6.8BQ2'25, Long-term debt: $7.0BQ3'25, Cash and equivalents: $1.3BQ3'25, Long-term debt: $9.8BQ3'25Q4'25, Cash and equivalents: $1.1BQ4'25, Long-term debt: $8.8BQ1'26, Cash and equivalents: $839MQ1'26, Long-term debt: $9.9BQ1'26Q2'26, Cash and equivalents: $593MQ2'26, Long-term debt: $9.4BQ3'26, Cash and equivalents: $524MQ3'26, Long-term debt: $8.9BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Bunge Global SA income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue23,80424,04121,86123,76222,15512,76911,64313,542+7.4%
Cost of revenue22,47222,36021,09522,75121,09212,03111,04612,461+6.5%
Gross profit1,3321,6817661,0111,0637385971,081+25.3%
Research and development—————————
Selling, general and administrative605606531637678418380451−10.8%
Operating income—————————
Other income (expense)173953(57)7718782230−77.9%
Pretax income5159436186270494284730+90.7%
Income tax168236(14)(2)8612480100+95.3%
Net income3186786895166354201602+91.6%
Diluted EPS ($)1.643.470.350.490.842.611.484.36+95.2%
Diluted shares (millions)194195196—198136135——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Bunge Global SA balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents5245938391,1351,3156,7903,2453,311−60.2%
Short-term investments3661957608611,848347638484−80.2%
Total current assets29,20926,21527,09424,39126,71921,44517,37315,958+9.3%
Total assets49,65646,78247,57644,52846,29831,15426,66024,899+7.3%
Total current liabilities19,43516,73416,94015,12716,09710,3848,5357,435+20.7%
Long-term debt8,9449,4269,9478,8319,8097,0444,7144,694−8.8%
Total liabilities—————————
Stockholders’ equity16,29615,95316,04515,90415,76810,88310,5789,913+3.3%
Shares outstanding (millions)192192194194193200134134—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.

Bunge Global SA cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 29, 2026Q2 FY2026ended Jun 30, 2026filed Jul 29, 2026Q1 FY2026ended Mar 31, 2026filed Apr 29, 2026Q4 FY2025ended Dec 31, 2025filed Feb 19, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow(1,176)(585)(541)1,347854(1,072)(285)1,053−237.7%
Capital expenditures384443336538469406310489−18.1%
Free cash flow (CFO − capex)(1,560)(1,028)(877)809385(1,478)(595)564−505.2%
Depreciation and amortization248256238226241116120123+2.9%
Share repurchases—————————
Dividends paid1391391361351399491910.0%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 19, 2026.

Income statement

Bunge Global SA income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2024FY2021ended Dec 31, 2021filed Feb 22, 2024
Revenue70,32953,10859,54067,23259,152
Cost of revenue66,92049,71554,69563,55055,789
Gross profit3,4093,3934,8453,6823,363
Research and development2830353333
Selling, general and administrative2,1131,7761,7151,3691,234
Operating income—————
Other income (expense)289442129(9)509
Pretax income1,1341,5243,0512,0662,565
Income tax288336714388398
Net income8161,1372,2431,6102,078
Diluted EPS ($)4.917.9914.8710.5113.64
Diluted shares (millions)166142151153152

Balance sheet

Bunge Global SA balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2024FY2021ended Dec 31, 2021filed Feb 22, 2024
Cash and equivalents1,1353,3112,6021,104902
Short-term investments861484105119—
Total current assets24,39115,95816,35016,758—
Total assets44,52824,89925,37224,58023,819
Total current liabilities15,1277,4357,6879,600—
Long-term debt8,8314,6944,0803,259—
Total liabilities—————
Stockholders’ equity15,9049,91310,8519,224—
Shares outstanding (millions)194134143——

Cash flow statement

Bunge Global SA cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 19, 2026FY2024ended Dec 31, 2024filed Feb 20, 2025FY2023ended Dec 31, 2023filed Feb 22, 2024FY2022ended Dec 31, 2022filed Feb 22, 2024FY2021ended Dec 31, 2021filed Feb 22, 2024
Operating cash flow8441,9003,308(5,549)(2,894)
Capital expenditures1,7231,3761,122555399
Free cash flow (CFO − capex)(879)5242,186(6,104)(3,293)
Depreciation and amortization703468451408424
Share repurchases5511,100600200100
Dividends paid459378383349289

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$161K
1 purchases by 1 insider; officers and directors $161K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$689K
2 purchases by 1 insider; officers and directors $689K
Sold, twelve months
$3M
3 sales by 2 insiders; officers and directors $3M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 1, 2026Isman AdrianDirectoraward10$119.25$1K3,330Sep 3, 2026
Sep 1, 2026Dimopoulos ChristosEVP and CSOaward160$119.25$19K118,514Sep 3, 2026
Sep 1, 2026McGurk Monica HouleDirectoraward10$119.25$1K7,098Sep 3, 2026
Sep 1, 2026Sears KellieChief Human Resources Officeraward117$119.25$14K31,874Sep 3, 2026
Sep 1, 2026Zenuk Mark NDirectoraward20$119.25$2K24,032Sep 3, 2026
Sep 1, 2026Podwika JosephChief Legal Officeraward139$119.25$17K92,271Sep 3, 2026
Sep 1, 2026Heckman Gregory AChief Executive Officer, Directoraward992$119.25$118K276,765Sep 3, 2026
Sep 1, 2026Browner Carol M.Directoraward10$119.25$1K30,625Sep 3, 2026
Sep 1, 2026Jojo Linda PDirectoraward10$119.25$1K3,612Sep 3, 2026
Sep 1, 2026Winship Henry Ward IVDirectoraward10$119.25$1K34,483Sep 3, 2026
Sep 1, 2026Simmons Jerry Matthews JRController, Principal Actg Offaward55$119.25$7K58,998Sep 3, 2026
Sep 1, 2026Lustosa de Andrade Eliane AleixoDirectoraward10$119.25$1K7,292Sep 3, 2026
Sep 1, 2026Simril KennethDirectoraward10$119.25$1K9,824Sep 3, 2026
Sep 1, 2026Mahoney ChristopherDirectoraward10$119.25$1K14,830Sep 3, 2026
Sep 1, 2026Jensen AnneDirectoraward10$119.25$1K3,330Sep 3, 2026
Sep 1, 2026Garros JulioChief Operating Officeraward253$119.25$30K142,899Sep 3, 2026
Sep 1, 2026Walt MarkusDirectoraward10$119.25$1K3,746Sep 3, 2026
Sep 1, 2026Neppl John WChief Financial Officeraward253$119.25$30K149,448Sep 3, 2026
Aug 4, 2026Mahoney ChristopherDirectoropen-market buy1,500$107.60$161K14,820Aug 4, 2026
Jul 31, 2026Mahoney ChristopherDirectoropen-market buy5,000$105.53$528K13,320Aug 4, 2026
Jun 1, 2026Mahoney ChristopherDirectoraward9$126.92$1K8,320Jun 3, 2026
Jun 1, 2026McGurk Monica HouleDirectoraward9$126.92$1K7,088Jun 3, 2026
Jun 1, 2026Dimopoulos ChristosEVP and CSOaward149$126.92$19K118,354Jun 3, 2026
Jun 1, 2026Simmons Jerry Matthews JRController, Principal Actg Offaward51$126.92$6K58,943Jun 3, 2026
Jun 1, 2026Zenuk Mark NDirectoraward18$126.92$2K24,012Jun 3, 2026

Full insider history for Bunge Global SA, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
BUNGE GLOBAL SA, CIK 1996862 on EDGAR
Extract generated
November 1, 2026
Withheld
none
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: not filed
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/BG.json